Emtora Biosciences
PrivateLast Round
Grant
May 22, 2025
Total Funding Raised
$32.17M
Company Overview
Emtora Biosciences is a clinical-stage biopharmaceutical company that develops eRapa, a proprietary micro-encapsulated formulation of rapamycin for the treatment of cancer and rare genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emtora Biosciences Comparables
Compare Emtora Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tornado Therapeutics | 77% | |
| Recursion Pharmaceuticals | 77% | |
| S.L.A. Pharma AG | 75% | |
Emtora Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 22, 2025 | ||||
| Grant | Aug 17, 2022 | ||||
| Grant | Apr 1, 2020 | ||||
| Grant | Aug 21, 2019 | ||||
| Convertible Debt | Feb 28, 2019 | ||||
Series A | Jun 2, 2015 |
Emtora Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Cancer Prevention and Research Institute of Texas (CPRIT) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 22, 2025
$3M grant received from CPRIT
- Apr 1, 2020
Secured $2.8M from the National Cancer Institute.
Emtora Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Emtora Biosciences's valuation, stock price, and market status.